New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 22, 2014
07:10 EDTMBII, EVGNEvogene, Marrone Bio sign multi-year collaborative agreement
Evogene (EVGN) and Marrone Bio Innovations (MBII) announced the signing of a multiyear collaborative agreement targeting the joint discovery of novel modes of biological action for insect control, followed by the development and commercialization of new insect control products by each of the companies. The partnership will leverage the expertise and distinct assets and capabilities of each company in its respective field. The companies will utilize the collaboration's joint assets to separately develop and commercialize products. Specifically, Evogene will develop biotechnology insect resistance seeds, while MBI will develop biologically-based insecticides. The parties have agreed on revenue sharing from all insect control products developed through the collaboration
News For EVGN;MBII From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 21, 2015
08:42 EDTMBIIMarrone Bio receives letter of continued noncompliance from Nasdaq
Marrone Bio announced that, as anticipated, it has received a letter from the Listing Qualifications Staff of The NASDAQ Stock Market notifying the company of its continued noncompliance with NASDAQ Listing Rule 5250(c)(1) as a result of the company's failure to timely file its Quarterly Report on Form 10-Q for the three months ended June 30 on August 15. As reported in the company's Notification of Late Filing on Form 12b-25 filed with the SEC on August 17, the Form 10-Q will not be filed with the SEC until after the completion of company management's evaluation of the necessity, nature and scope of any restatements to its previously filed financial statements. The company currently expects that it will be able to file all delinquent reports, including the Form 10-Q, prior the November 9 expiration of the stay on suspension of trading granted by NASDAQ for the company to regain compliance with NASDAQ's filing requirement.
08:40 EDTMBIIMarrone Bio COO James Iademarco to resign
Marrone Bio Innovations announced that James Iademarco, the company's president and COO since January, has elected to resign effective August 31. To assist with the transition of various pending matters, Iademarco has agreed to remain available to advise the company in a consulting capacity for an additional period of up to 90 days.
August 17, 2015
08:36 EDTEVGNEvogene to establish validation capabilities for soybean cyst nematodes
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use